14C-LY3009104

LY3009104 · Eli Lilly and Company

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for 14C-LY3009104, covering 2017-04-21 to 2017-04-21. Get the full timeline:

Most recent: Clinical Trial Update: Disposition of 14C-LY3009104 Following Oral Administration in Healthy Human Subjects [Phase 1]